VOLUME 7 (2016)
Table of Contents
Editorial
|
| Natural polymerase fusion as an initiation regulator |
|
https://doi.org/10.18632/oncotarget.9565
|
| 35498-35499 |
Research Papers: Gerotarget (Focus on Aging)
|
| VPO1 mediates oxidation of LDL and formation of foam cells |
|
https://doi.org/10.18632/oncotarget.9193
|
| 35500-35511 |
|
| Age serum 25hydroxyvitamin D and vitamin D receptor VDR expression and function in peripheral blood mononuclear cells |
|
https://doi.org/10.18632/oncotarget.9398
|
| 35512-35521 |
|
| The potential role of epigenetic modulations in BPPV maneuver exercises |
|
https://doi.org/10.18632/oncotarget.9446
|
| 35522-35534 |
|
| Deficiency of myeloidrelated proteins 8 and 14 Mrp8/Mrp14 does not block inflammaging but prevents steatosis |
|
https://doi.org/10.18632/oncotarget.9550
|
| 35535-35551 |
|
| Subacute systemic erythropoietin administration reduces ischemic brain injury in an agedependent manner |
|
https://doi.org/10.18632/oncotarget.9652
|
| 35552-35561 |
Research Papers: Pathology
|
| Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque |
|
https://doi.org/10.18632/oncotarget.9384
|
| 35562-35576 |
|
| Impaired macrophage autophagy induces systemic insulin resistance in obesity |
|
https://doi.org/10.18632/oncotarget.9590
|
| 35577-35591 |
|
| The molecular mechanism of G2/M cell cycle arrest induced by AFB1 in the jejunum |
|
https://doi.org/10.18632/oncotarget.9594
|
| 35592-35606 |
|
| MiR4995p protects cardiomyocytes against ischaemic injury via antiapoptosis by targeting PDCD4 |
|
https://doi.org/10.18632/oncotarget.9597
|
| 35607-35617 |
|
| PolyADPribose polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy |
|
https://doi.org/10.18632/oncotarget.8343
|
| 35618-35631 |
|
| Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females |
|
https://doi.org/10.18632/oncotarget.9691
|
| 35632-35642 |
Research Papers: Immunology
|
| Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation |
|
https://doi.org/10.18632/oncotarget.9543
|
| 35643-35654 |
|
| Using lymph node swelling as a potential biomarker for successful vaccination |
|
https://doi.org/10.18632/oncotarget.9580
|
| 35655-35669 |
|
| Haemonchus contortus excretory and secretory proteins HcESPs suppress functions of goat PBMCs in vitro |
|
https://doi.org/10.18632/oncotarget.9589
|
| 35670-35679 |
|
| Medicinal herbs Fructus corni and Semen cuscutae suppress allograft rejection via distinct immune mechanisms |
|
https://doi.org/10.18632/oncotarget.9680
|
| 35680-35691 |
Research Papers: Autophagy and Cell Death
|
| Autophagy maintains ubiquitinationproteasomal degradation of Sirt3 to limit oxidative stress in K562 leukemia cells |
|
https://doi.org/10.18632/oncotarget.9592
|
| 35692-35702 |
|
| Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells |
|
https://doi.org/10.18632/oncotarget.9601
|
| 35703-35723 |
Research Papers: Chromosome
|
| FBW7 regulates DNA interstrand crosslink repair by modulating FAAP20 degradation |
|
https://doi.org/10.18632/oncotarget.9595
|
| 35724-35740 |
Research Papers
|
| Transtinib a potent tyrosine kinase inhibitor inhibits L858R/T790M mutant NSCLC cell lines and xenografts |
|
https://doi.org/10.18632/oncotarget.7140
|
| 35741-35752 |
|
| Dual mTORC1/2 inhibition induces antiproliferative effect in NF1associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells |
|
https://doi.org/10.18632/oncotarget.7099
|
| 35753-35767 |
|
| Quantitative assessment of TIM3 polymorphisms and cancer risk in Chinese Han population |
|
https://doi.org/10.18632/oncotarget.8157
|
| 35768-35775 |
|
| A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer |
|
https://doi.org/10.18632/oncotarget.7980
|
| 35776-35788 |
|
| MicroRNA320 suppresses colorectal cancer by targeting SOX4 FOXM1 and FOXQ1 |
|
https://doi.org/10.18632/oncotarget.8937
|
| 35789-35802 |
|
| The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second or thirdline for advanced nonsmallcell lung cancer patients with wildtype or unknown EGFR status |
|
https://doi.org/10.18632/oncotarget.8130
|
| 35803-35812 |
|
| Strong evidence for LncRNA ZNRD1AS1 and its functional Cis eQTL locus contributing more to the susceptibility of lung cancer |
|
https://doi.org/10.18632/oncotarget.8411
|
| 35813-35817 |
|
| Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer |
|
https://doi.org/10.18632/oncotarget.9027
|
| 35818-35831 |
|
| Similar cisplatin sensitivity of HPVpositive and negative HNSCC cell lines |
|
https://doi.org/10.18632/oncotarget.9028
|
| 35832-35842 |
|
| Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis |
|
https://doi.org/10.18632/oncotarget.8561
|
| 35843-35852 |
|
| Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry |
|
https://doi.org/10.18632/oncotarget.8221
|
| 35853-35864 |
|
| Determination of radiotherapeutic target zones for thoracic esophageal squamous cell cancer with lower cervical lymph node metastasis according to CTimages |
|
https://doi.org/10.18632/oncotarget.9094
|
| 35865-35873 |
|
| Polyphenolrich Avicennia marina leaf extracts induce apoptosis in human breast and liver cancer cells and in a nude mouse xenograft model |
|
https://doi.org/10.18632/oncotarget.8624
|
| 35874-35893 |
|
| Effective elimination of liver cancer stemlike cells by CD90 antibody targeted thermosensitive magnetoliposomes |
|
https://doi.org/10.18632/oncotarget.9116
|
| 35894-35916 |
|
| Transforming growth factorβ promotes aggressiveness and invasion of clear cell renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.9177
|
| 35917-35931 |
|
| The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer |
|
https://doi.org/10.18632/oncotarget.8321
|
| 35932-35945 |
|
| The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.9371
|
| 35946-35959 |
|
| HsamiR134 suppresses nonsmall cell lung cancer NSCLC development through downregulation of CCND1 |
|
https://doi.org/10.18632/oncotarget.8482
|
| 35960-35978 |
|
| Clinical and genetic features of lung squamous cell cancer in neversmokers |
|
https://doi.org/10.18632/oncotarget.8745
|
| 35979-35988 |
|
| Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with microenvironment derived cytokines |
|
https://doi.org/10.18632/oncotarget.8540
|
| 35989-36001 |
|
| Dendrimer antibody conjugate to target and image HER2 overexpressing cancer cells |
|
https://doi.org/10.18632/oncotarget.9081
|
| 36002-36013 |
|
| NME8 rs2718058 polymorphism with Alzheimer’s disease risk: a replication and metaanalysis |
|
https://doi.org/10.18632/oncotarget.9086
|
| 36014-36020 |
|
| Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and gliomainduced brain edema |
|
https://doi.org/10.18632/oncotarget.8651
|
| 36021-36033 |
|
| Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of cMyc oncogene |
|
https://doi.org/10.18632/oncotarget.9105
|
| 36034-36048 |
|
| Oncogenic function of the homeobox A13long noncoding RNA HOTTIPinsulin growth factorbinding protein 3 axis in human gastric cancer |
|
https://doi.org/10.18632/oncotarget.9102
|
| 36049-36064 |
|
| Clinicopathological and prognostic significance of regulatory T cells in patients with nonsmall cell lung cancer: A systematic review with metaanalysis |
|
https://doi.org/10.18632/oncotarget.9130
|
| 36065-36073 |
|
| Defective STAT1 activation associated with impaired IFNγ production in NK and T lymphocytes from metastatic melanoma patients treated with IL2 |
|
https://doi.org/10.18632/oncotarget.8683
|
| 36074-36091 |
|
| Identification of breast cancer candidate genes using gene coexpression and proteinprotein interaction information |
|
https://doi.org/10.18632/oncotarget.9132
|
| 36092-36100 |
|
| Identification of a novel partner gene KIAA1217 fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.9137
|
| 36101-36114 |
|
| EZH2mediated repression of GSK3β and TP53 promotes Wnt/βcatenin signalingdependent cell expansion in cervical carcinoma |
|
https://doi.org/10.18632/oncotarget.8741
|
| 36115-36129 |
|
| Which melanoma patient carries a BRAFmutation A comparison of predictive models |
|
https://doi.org/10.18632/oncotarget.9143
|
| 36130-36137 |
|
| Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death |
|
https://doi.org/10.18632/oncotarget.9147
|
| 36138-36153 |
|
| Novel 1 3N OSpiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatininduced cytotoxicity in cervical cancer cells |
|
https://doi.org/10.18632/oncotarget.8959
|
| 36154-36167 |
|
| SK3/TRPC1/Orai1 complex regulates SOCEdependent colon cancer cell migration: a novel opportunity to modulate antiEGFR mAb action by the alkyllipid Ohmline |
|
https://doi.org/10.18632/oncotarget.8786
|
| 36168-36184 |
|
| Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTORS6K1 pathway |
|
https://doi.org/10.18632/oncotarget.9154
|
| 36185-36197 |
|
| Clinical significance of the preoperative platelet count and platelettolymphocyte ratio PLTPLR in patients with surgically resected nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.8809
|
| 36198-36206 |
|
| Reduced miR200b and miR200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1 |
|
https://doi.org/10.18632/oncotarget.9183
|
| 36207-36219 |
|
| A miR200c/141BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells |
|
https://doi.org/10.18632/oncotarget.8811
|
| 36220-36234 |
|
| Coinhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma |
|
https://doi.org/10.18632/oncotarget.8827
|
| 36235-36246 |
|
| miR133b inhibits glioma cell proliferation and invasion by targeting Sirt1 |
|
https://doi.org/10.18632/oncotarget.9198
|
| 36247-36254 |
|
| The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway |
|
https://doi.org/10.18632/oncotarget.9199
|
| 36255-36265 |
|
| TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lowerrisk myelodysplastic syndromes |
|
https://doi.org/10.18632/oncotarget.9200
|
| 36266-36279 |
|
| In vitro functional characterization of prostaglandinendoperoxide synthase 2 during chondrocyte hypertrophic differentiation |
|
https://doi.org/10.18632/oncotarget.8889
|
| 36280-36292 |
|
| Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data |
|
https://doi.org/10.18632/oncotarget.9202
|
| 36293-36310 |
|
| Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor Korean Lung Cancer Consortium |
|
https://doi.org/10.18632/oncotarget.8904
|
| 36311-36320 |
|
| Targeting miR213p inhibits proliferation and invasion of ovarian cancer cells |
|
https://doi.org/10.18632/oncotarget.9216
|
| 36321-36337 |
|
| MicroRNA126 induces autophagy by altering cell metabolism in malignant mesothelioma |
|
https://doi.org/10.18632/oncotarget.8916
|
| 36338-36352 |
|
| DNA damaging agentinduced apoptosis is regulated by MCL1 phosphorylation and degradation mediated by the Noxa/MCL1/CDK2 complex |
|
https://doi.org/10.18632/oncotarget.9217
|
| 36353-36365 |
|
| Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma |
|
https://doi.org/10.18632/oncotarget.8917
|
| 36366-36381 |
|
| Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1BCR/ABL axis |
|
https://doi.org/10.18632/oncotarget.8871
|
| 36382-36394 |
|
| ER stress inducer tunicamycin suppresses the selfrenewal of gliomainitiating cell partly through inhibiting Sox2 translation |
|
https://doi.org/10.18632/oncotarget.8954
|
| 36395-36406 |
|
| AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression |
|
https://doi.org/10.18632/oncotarget.9239
|
| 36407-36418 |
|
| Functional cooperation between KCa31 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis |
|
https://doi.org/10.18632/oncotarget.9261
|
| 36419-36435 |
|
| Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imaging |
|
https://doi.org/10.18632/oncotarget.9262
|
| 36436-36446 |
|
| The role of VDR and BIM in potentiation of cytarabine–induced cell death in human AML blasts |
|
https://doi.org/10.18632/oncotarget.8998
|
| 36447-36460 |
|
| Combining 2deoxyDglucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress |
|
https://doi.org/10.18632/oncotarget.9263
|
| 36461-36473 |
|
| Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.9015
|
| 36474-36488 |
|
| ISL1 a novel regulator of CCNB1 CCNB2 and cMYC genes promotes gastric cancer cell proliferation and tumor growth |
|
https://doi.org/10.18632/oncotarget.9269
|
| 36489-36500 |
|
| BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.9038
|
| 36501-36509 |
|
| CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway |
|
https://doi.org/10.18632/oncotarget.9058
|
| 36510-36528 |
|
| MicroRNA300 inhibited glioblastoma progression through ROCK1 |
|
https://doi.org/10.18632/oncotarget.9068
|
| 36529-36538 |
|
| p70S6K promotes IL6induced epithelialmesenchymal transition and metastasis of head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.9282
|
| 36539-36550 |
|
| Zinc finger protein 91 ZFP91 activates HIF1α via NFκB/p65 to promote proliferation and tumorigenesis of colon cancer |
|
https://doi.org/10.18632/oncotarget.9070
|
| 36551-36562 |
|
| Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.9095
|
| 36563-36576 |
|
| Downregulated miR31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2 |
|
https://doi.org/10.18632/oncotarget.9288
|
| 36577-36589 |
|
| Genetic alteration profiling of patients with resected squamous cell lung carcinomas |
|
https://doi.org/10.18632/oncotarget.9096
|
| 36590-36601 |
|
| Targeted photochemo therapy of malignancy on the chest wall while cardiopulmonary avoidance based on Fe3O4@ZnO nanocomposites |
|
https://doi.org/10.18632/oncotarget.9123
|
| 36602-36613 |
|
| MicroRNA1263p suppresses cell proliferation by targeting PIK3R2 in Kaposi’s sarcoma cells |
|
https://doi.org/10.18632/oncotarget.9311
|
| 36614-36621 |
|
| Plasma lipidomics profiling identified lipid biomarkers in distinguishing earlystage breast cancer from benign lesions |
|
https://doi.org/10.18632/oncotarget.9124
|
| 36622-36631 |
|
| Stratified analysis reveals chemokinelike factor CKLF as a potential prognostic marker in the MSIimmune consensus molecular subtype CMS1 of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.9126
|
| 36632-36644 |
|
| Circulating tumor cells as a prognostic and predictive marker in gastrointestinal stromal tumors: a prospective study |
|
https://doi.org/10.18632/oncotarget.9128
|
| 36645-36654 |
|
| The antiapoptotic and prognostic value of fibroblast growth factor 9 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.9131
|
| 36655-36665 |
|
| Targeting carbonic anhydrase IX improves the anticancer efficacy of mTOR inhibitors |
|
https://doi.org/10.18632/oncotarget.9134
|
| 36666-36680 |
|
| OTUB1catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.9160
|
| 36681-36697 |
|
| Matricellular protein CCN1 mediates doxorubicininduced cardiomyopathy in mice |
|
https://doi.org/10.18632/oncotarget.9162
|
| 36698-36710 |
|
| RMEL3 a novel BRAFV600Eassociated long noncoding RNA is required for MAPK and PI3K signaling in melanoma |
|
https://doi.org/10.18632/oncotarget.9164
|
| 36711-36718 |
|
| Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2activated metabolic reprogramming and ROS detoxification |
|
https://doi.org/10.18632/oncotarget.9165
|
| 36719-36732 |
|
| Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscleinvasive bladder cancer |
|
https://doi.org/10.18632/oncotarget.9166
|
| 36733-36742 |
|
| MiR507 inhibits the migration and invasion of human breastcancer cells through Flt1 suppression |
|
https://doi.org/10.18632/oncotarget.9163
|
| 36743-36754 |
|
| Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer |
|
https://doi.org/10.18632/oncotarget.9337
|
| 36755-36766 |
|
| Desgammacarboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways |
|
https://doi.org/10.18632/oncotarget.9168
|
| 36767-36782 |
|
| EpsteinBarr virus encoded miRBART11 promotes inflammationinduced carcinogenesis by targeting FOXP1 |
|
https://doi.org/10.18632/oncotarget.9170
|
| 36783-36799 |
|
| Cterminus of MUC16 activates Wnt signaling pathway through its interaction with βcatenin to promote tumorigenesis and metastasis |
|
https://doi.org/10.18632/oncotarget.9191
|
| 36800-36813 |
|
| Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.9192
|
| 36814-36828 |
|
| GDNF secreted from adiposederived stem cells stimulates VEGFindependent angiogenesis |
|
https://doi.org/10.18632/oncotarget.9208
|
| 36829-36841 |
|
| Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERKJNK signaling pathways |
|
https://doi.org/10.18632/oncotarget.9209
|
| 36842-36853 |
|
| Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis |
|
https://doi.org/10.18632/oncotarget.9210
|
| 36854-36864 |
|
| JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a highrisk subgroup of HER2positive gastric carcinoma patients |
|
https://doi.org/10.18632/oncotarget.9211
|
| 36865-36884 |
|
| Pathway analysis of expressionrelated SNPs on genomewide association study of basal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.9212
|
| 36885-36895 |
|
| CCL5 promotes VEGFC production and induces lymphangiogenesis by suppressing miR507 in human chondrosarcoma cells |
|
https://doi.org/10.18632/oncotarget.9213
|
| 36896-36908 |
|
| Methylationmediated repression of microRNA1292 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.9377
|
| 36909-36923 |
|
| Intestinespecific homeobox ISX upregulates E2F1 expression and related oncogenic activities in HCC |
|
https://doi.org/10.18632/oncotarget.9228
|
| 36924-36939 |
|
| Estrogen regulates miRNA expression: implication of estrogen receptor and miR124/AKT2 in tumor growth and angiogenesis |
|
https://doi.org/10.18632/oncotarget.9230
|
| 36940-36955 |
|
| The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.9231
|
| 36956-36970 |
|
| Posttranslational regulation of the cleaved fragment of Par4 in ovarian and endometrial cancer cells |
|
https://doi.org/10.18632/oncotarget.9235
|
| 36971-36987 |
|
| Paracrine regulation of matrix metalloproteinases contributes to cancer cell invasion by hepatocellular carcinomasecreted 1433σ |
|
https://doi.org/10.18632/oncotarget.9234
|
| 36988-36999 |
|
| Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS |
|
https://doi.org/10.18632/oncotarget.9454
|
| 37000-37012 |
|
| The antiHER3 ErbB3 therapeutic antibody 9F7F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2 dependent ITCH/AIP4 activation |
|
https://doi.org/10.18632/oncotarget.9455
|
| 37013-37029 |
|
| TATIL24KDELinduced apoptosis is inhibited by survivin but restored by the small molecular survivin inhibitor YM155 in cancer cells |
|
https://doi.org/10.18632/oncotarget.9458
|
| 37030-37042 |
|
| Metabolomic screening of prediagnostic serum samples identifies association between α and γtocopherols and glioblastoma risk |
|
https://doi.org/10.18632/oncotarget.9242
|
| 37043-37053 |
|
| MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma |
|
https://doi.org/10.18632/oncotarget.9244
|
| 37054-37063 |
|
| Copper as a target for prostate cancer therapeutics: copperionophore pharmacology and altering systemic copper distribution |
|
https://doi.org/10.18632/oncotarget.9245
|
| 37064-37080 |
|
| Exploiting macrophages as targeted carrier to guide nanoparticles into glioma |
|
https://doi.org/10.18632/oncotarget.9464
|
| 37081-37091 |
|
| Integrity of a HPV11 infection cell model and identification of Epigallocatechin3gallate as a potential HPV11 inhibitor |
|
https://doi.org/10.18632/oncotarget.9249
|
| 37092-37102 |
|
| The novel choline kinase inhibitor ICLCCIC0019 reprograms cellular metabolism and inhibits cancer cell growth |
|
https://doi.org/10.18632/oncotarget.9466
|
| 37103-37120 |
|
| Pseudomonas aeruginosa mannosesensitive hemagglutinin inhibits proliferation and invasion via the PTEN/AKT pathway in HeLa cells |
|
https://doi.org/10.18632/oncotarget.9467
|
| 37121-37131 |
|
| Genomewide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA |
|
https://doi.org/10.18632/oncotarget.9469
|
| 37132-37144 |
|
| Met and its ligand HGF are associated with clinical outcome in breast cancer |
|
https://doi.org/10.18632/oncotarget.9268
|
| 37145-37159 |
|
| Sensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase ALK alterations in patients with nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.9471
|
| 37160-37176 |
|
| Mouse double minute 2 MDM2 upregulates Snail expression and induces epithelialtomesenchymal transition in breast cancer cells in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.9287
|
| 37177-37191 |
|
| Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine |
|
https://doi.org/10.18632/oncotarget.9293
|
| 37192-37204 |
|
| Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.9291
|
| 37205-37214 |
|
| GADD45β induction by Sadenosylmethionine inhibits hepatocellular carcinoma cell proliferation during acute ischemiahypoxia |
|
https://doi.org/10.18632/oncotarget.9295
|
| 37215-37225 |
|
| Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes TenascinC as a stromal biomarker for colorectal cancer metastasis |
|
https://doi.org/10.18632/oncotarget.9362
|
| 37226-37237 |
|
| Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection |
|
https://doi.org/10.18632/oncotarget.9361
|
| 37238-37249 |
|
| A unique set of 6 circulating microRNAs for early detection of nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.9363
|
| 37250-37259 |
|
| Phosphorylation of Ecadherin at threonine 790 by protein kinase Cδ reduces βcatenin binding and suppresses the function of Ecadherin |
|
https://doi.org/10.18632/oncotarget.9403
|
| 37260-37276 |
Clinical Research Papers
|
| The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.8671
|
| 37277-37287 |
|
| Implementation of a rapid learning platform: Predicting 2year survival in laryngeal carcinoma patients in a clinical setting |
|
https://doi.org/10.18632/oncotarget.8755
|
| 37288-37296 |
|
| Neoadjuvant modified TPF docetaxel cisplatin fluorouracil for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients |
|
https://doi.org/10.18632/oncotarget.8934
|
| 37297-37304 |
|
| Prognostic significance of cancer family history for patients with gastric cancer: a single center experience from China |
|
https://doi.org/10.18632/oncotarget.9032
|
| 37305-37318 |
|
| Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.9104
|
| 37319-37330 |
Reviews
|
| The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer |
|
https://doi.org/10.18632/oncotarget.7949
|
| 37331-37346 |
|
| Posttranslational modificationregulated leukocyte adhesion and migration |
|
https://doi.org/10.18632/oncotarget.8135
|
| 37347-37360 |
|
| The significant prognostic value of circulating tumor cells in triplenegative breast cancer: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.8156
|
| 37361-37369 |
|
| Biomarker development in METtargeted therapy |
|
https://doi.org/10.18632/oncotarget.8276
|
| 37370-37389 |
|
| Dietary fat intake and ovarian cancer risk: a metaanalysis of epidemiological studies |
|
https://doi.org/10.18632/oncotarget.8940
|
| 37390-37406 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC